Guardian Connect App Connectivity To Carelink Recalled
The Guardian Connect App Connectivity to Carelink Personal Software has been recalled by Product Safety Australia.
The Guardian Connect App is used as the primary display on personal mobile devices for the monitoring of blood glucose levels in persons with diabetes. The recall does not impact the Guardian Connect app itself.
According to the watchdog, there have been reports of data connectivity disruptions to the CareLink software.
As a result of these disruptions, Care partners may not receive SMS alerts from the Guardian Connect app, Care partner remote access monitoring in the CareLink Connect web app may show data gaps, or users may see data gaps in reports.
“If inaccurate blood glucose information is used to determine the insulin dose or make treatment decisions, this may lead to incorrect dosing decisions which can lead to serious health complications,” Product Safety Australia wrote.